189 related articles for article (PubMed ID: 25593792)
21. Porcine N-acetylgalactosamine 6-sulfatase (GALNS) cDNA sequence and expression in developing teeth.
Yamakoshi Y; Hu JC; Liu S; Sun X; Zhang C; Oida S; Fukae M; Simmer JP
Connect Tissue Res; 2002; 43(2-3):167-75. PubMed ID: 12489154
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene.
Terzioglu M; Tokatli A; Coskun T; Emre S
Hum Mutat; 2002 Dec; 20(6):477-8. PubMed ID: 12442278
[TBL] [Abstract][Full Text] [Related]
23. Enzyme replacement therapy in a murine model of Morquio A syndrome.
Tomatsu S; Montaño AM; Ohashi A; Gutierrez MA; Oikawa H; Oguma T; Dung VC; Nishioka T; Orii T; Sly WS
Hum Mol Genet; 2008 Mar; 17(6):815-24. PubMed ID: 18056156
[TBL] [Abstract][Full Text] [Related]
24. Bromocriptine as a Novel Pharmacological Chaperone for Mucopolysaccharidosis IV A.
Olarte-Avellaneda S; Cepeda Del Castillo J; Rojas-Rodriguez AF; Sánchez O; Rodríguez-López A; Suárez García DA; Pulido LMS; Alméciga-Díaz CJ
ACS Med Chem Lett; 2020 Jul; 11(7):1377-1385. PubMed ID: 32676143
[TBL] [Abstract][Full Text] [Related]
25. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A).
Tomatsu S; Montaño AM; Nishioka T; Gutierrez MA; Peña OM; Tranda Firescu GG; Lopez P; Yamaguchi S; Noguchi A; Orii T
Hum Mutat; 2005 Dec; 26(6):500-12. PubMed ID: 16287098
[TBL] [Abstract][Full Text] [Related]
26. Elosulfase alfa.
Haddley K
Drugs Today (Barc); 2014 Jul; 50(7):475-83. PubMed ID: 25101330
[TBL] [Abstract][Full Text] [Related]
27. Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins.
Tomatsu S; Vogler C; Montaño AM; Gutierrez M; Oikawa H; Dung VC; Orii T; Noguchi A; Sly WS
Mol Genet Metab; 2007 Jul; 91(3):251-8. PubMed ID: 17498992
[TBL] [Abstract][Full Text] [Related]
28. Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity.
Shams S; Barazandeh Tehrani M; Civallero G; Minookherad K; Giugliani R; Setoodeh A; Haghi Ashtiani MT
J Diabetes Metab Disord; 2017; 16():37. PubMed ID: 28904929
[TBL] [Abstract][Full Text] [Related]
29. Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy.
Chen H; Khan S; Celik B; Suzuki Y; Ago Y; Tomatsu S
Mol Genet Genomic Med; 2021 Nov; 9(11):e1806. PubMed ID: 34623762
[TBL] [Abstract][Full Text] [Related]
30. Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease.
Fateen EM; El Mawgoud HA; Eissa NR; Ibrahim MM; Aglan MS; Essawi ML
Gene; 2017 Feb; 600():48-54. PubMed ID: 27825773
[TBL] [Abstract][Full Text] [Related]
31. Mucopolysaccharidosis IVA: identification of a common missense mutation I113F in the N-Acetylgalactosamine-6-sulfate sulfatase gene.
Tomatsu S; Fukuda S; Cooper A; Wraith JE; Rezvi GM; Yamagishi A; Yamada N; Kato Z; Isogai K; Sukegawa K
Am J Hum Genet; 1995 Sep; 57(3):556-63. PubMed ID: 7668283
[TBL] [Abstract][Full Text] [Related]
32. Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots.
Ullal AJ; Millington DS; Bali DS
Mol Genet Metab Rep; 2014; 1():461-464. PubMed ID: 27896123
[TBL] [Abstract][Full Text] [Related]
33. Integrated Management of an Adult Patient with Mucopolysaccharidosis type IVA: A Case Report with a Six-Year Follow-up.
Vergatti A; Abate V; Della Monica M; De Filippo G; Rendina D; Barbato A
Eur J Case Rep Intern Med; 2024; 11(1):004113. PubMed ID: 38223275
[TBL] [Abstract][Full Text] [Related]
34. Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).
Lyseng-Williamson KA
BioDrugs; 2014 Oct; 28(5):465-75. PubMed ID: 25200032
[TBL] [Abstract][Full Text] [Related]
35. Molecular therapy and nucleic acid adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice.
Rintz E; Celik B; Fnu N; Herreño-Pachón AM; Khan S; Benincore-Flórez E; Tomatsu S
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102211. PubMed ID: 38831899
[TBL] [Abstract][Full Text] [Related]
36. Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice.
Leal AF; Celik B; Fnu N; Khan S; Tomatsu S; Alméciga-Díaz CJ
Mol Ther Methods Clin Dev; 2023 Dec; 31():101153. PubMed ID: 38107675
[TBL] [Abstract][Full Text] [Related]
37. Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients.
Laradi S; Tukel T; Khediri S; Shabbeer J; Erazo M; Chkioua L; Chaabouni M; Ferchichi S; Miled A; Desnick RJ
Mol Genet Metab; 2006 Mar; 87(3):213-8. PubMed ID: 16378744
[TBL] [Abstract][Full Text] [Related]
38. Natural history of Morquio A patient with tracheal obstruction from birth to death.
Doherty C; Averill LW; Theroux M; Mackenzie WG; Pizarro C; Mason RW; Tomatsu S
Mol Genet Metab Rep; 2018 Mar; 14():59-67. PubMed ID: 29326877
[TBL] [Abstract][Full Text] [Related]
39. Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.
Tomatsu S; Mackenzie WG; Theroux MC; Mason RW; Thacker MM; Shaffer TH; Montaño AM; Rowan D; Sly W; Alméciga-Díaz CJ; Barrera LA; Chinen Y; Yasuda E; Ruhnke K; Suzuki Y; Orii T
Res Rep Endocr Disord; 2012 Dec; 2012(2):65-77. PubMed ID: 24839594
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Diagnosis of Mucopolysaccharidosis Type IVA With Compound Heterozygous Galactosamine-6 Sulfatase Variants and Biopsy of Replaced Femoral Heads.
Ma Y; Peng H; Hsiang F; Fang H; Du D; Jiang C; Wang Y; Chen C; Zhang C; Gao Y
Front Pediatr; 2022; 10():914889. PubMed ID: 35859948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
